Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Operation of Chain Pharmacies	528.81M	590.49M	634.15M	696.03M	693.22M
Operation of Chain Pharmacies Growth	-10.45%	-6.88%	-8.89%	0.41%	-
Elimination of Intersegment Sales	-592.07M	-708.24M	-696.22M	-717.95M	-823.96M
Pharmaceutical Manufacturing	1.80B	2.33B	2.11B	1.85B	1.88B
Pharmaceutical Manufacturing Growth	-22.80%	10.45%	14.29%	-1.57%	90.47%
Total	1.74B	2.21B	2.05B	1.83B	1.75B
Total Growth	-21.55%	8.05%	12.26%	4.55%	8.89%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Mainland China	1.74B	2.21B	2.05B	1.83B	1.75B
Mainland China Growth	-21.55%	8.05%	12.26%	4.55%	8.89%
Total	1.74B	2.21B	2.05B	1.83B	1.75B
Total Growth	-21.55%	8.05%	12.26%	4.55%	8.89%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 10, 2026

Data Sources Report a data error